国家主导的风险投资是资本主义国家主导的风险投资

IF 5.5 2区医学 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Biomaterials Science & Engineering Pub Date : 2024-05-20 DOI:10.1177/20438206241253566

Heather Whiteside

{"title":"国家主导的风险投资是资本主义国家主导的风险投资","authors":"Heather Whiteside","doi":"10.1177/20438206241253566","DOIUrl":null,"url":null,"abstract":"Structured around the questions posed by Su and Lim's research agenda, this commentary looks at the why of state-led venture capital (SVC) through state theory, the how of SVC through changes in the Business Development Bank of Canada, and the what of SVC through dynamics of capitalist public ownership.","PeriodicalId":8,"journal":{"name":"ACS Biomaterials Science & Engineering","volume":"90 3","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"State-led venture capital as capitalist state-led ventures\",\"authors\":\"Heather Whiteside\",\"doi\":\"10.1177/20438206241253566\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Structured around the questions posed by Su and Lim's research agenda, this commentary looks at the why of state-led venture capital (SVC) through state theory, the how of SVC through changes in the Business Development Bank of Canada, and the what of SVC through dynamics of capitalist public ownership.\",\"PeriodicalId\":8,\"journal\":{\"name\":\"ACS Biomaterials Science & Engineering\",\"volume\":\"90 3\",\"pages\":\"\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2024-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Biomaterials Science & Engineering\",\"FirstCategoryId\":\"96\",\"ListUrlMain\":\"https://doi.org/10.1177/20438206241253566\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Biomaterials Science & Engineering","FirstCategoryId":"96","ListUrlMain":"https://doi.org/10.1177/20438206241253566","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

摘要

围绕 Su 和 Lim 的研究议程所提出的问题，本评论通过国家理论探讨了国家主导型风险投资（SVC）的原因，通过加拿大商业发展银行的变化探讨了国家主导型风险投资（SVC）的方式，通过资本主义公有制的动态探讨了国家主导型风险投资（SVC）的内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

State-led venture capital as capitalist state-led ventures

Structured around the questions posed by Su and Lim's research agenda, this commentary looks at the why of state-led venture capital (SVC) through state theory, the how of SVC through changes in the Business Development Bank of Canada, and the what of SVC through dynamics of capitalist public ownership.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ACS Biomaterials Science & Engineering Materials Science-Biomaterials

CiteScore

10.30

自引率

3.40%

发文量

413

期刊介绍： ACS Biomaterials Science & Engineering is the leading journal in the field of biomaterials, serving as an international forum for publishing cutting-edge research and innovative ideas on a broad range of topics: Applications and Health – implantable tissues and devices, prosthesis, health risks, toxicology Bio-interactions and Bio-compatibility – material-biology interactions, chemical/morphological/structural communication, mechanobiology, signaling and biological responses, immuno-engineering, calcification, coatings, corrosion and degradation of biomaterials and devices, biophysical regulation of cell functions Characterization, Synthesis, and Modification – new biomaterials, bioinspired and biomimetic approaches to biomaterials, exploiting structural hierarchy and architectural control, combinatorial strategies for biomaterials discovery, genetic biomaterials design, synthetic biology, new composite systems, bionics, polymer synthesis Controlled Release and Delivery Systems – biomaterial-based drug and gene delivery, bio-responsive delivery of regulatory molecules, pharmaceutical engineering Healthcare Advances – clinical translation, regulatory issues, patient safety, emerging trends Imaging and Diagnostics – imaging agents and probes, theranostics, biosensors, monitoring Manufacturing and Technology – 3D printing, inks, organ-on-a-chip, bioreactor/perfusion systems, microdevices, BioMEMS, optics and electronics interfaces with biomaterials, systems integration Modeling and Informatics Tools – scaling methods to guide biomaterial design, predictive algorithms for structure-function, biomechanics, integrating bioinformatics with biomaterials discovery, metabolomics in the context of biomaterials Tissue Engineering and Regenerative Medicine – basic and applied studies, cell therapies, scaffolds, vascularization, bioartificial organs, transplantation and functionality, cellular agriculture